NDC11 64842072709
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 64842-0727-09 | 64842-0727 |
| 64842-0727-9 | 64842-0727 |
| 64842-727-09 | 64842-727 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INQOVI | CEDAZURIDINE AND DECITABINE | Taiho Pharmaceutical Co., Ltd. | 91a0f80b-f865-4d06-a40d-4d148d99ee71 | 2026-05-25 | Warnings, Adverse reactions | 64842-0727-9 64842-0727 64842072709 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.